Evidence map›Paper›PMID 39667795›Full record

ArticleBJGP open2025

Treatment patterns and burden of uncomplicated urinary tract infection in England: a retrospective cohort study.

Mark H Wilcox, Dave Heaton, Aruni Mulgirigama, Ashish V Joshi, Viktor Chirikov, Daniel C Gibbons, David Webb, Xiaocong L Marston, Myriam Na Alexander, Fanny S Mitrani-Gold

Abstract read
In one paragraph

Article in BJGP open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mark H WilcoxDepartment of Microbiology, University of Leeds, Leeds, UK.
Dave HeatonOPEN Health, Marlow, UK.
Aruni MulgirigamaGSK, London, UK.
Ashish V JoshiGSK, Collegeville, PA, US.
Viktor ChirikovOPEN Health, Bethesda, MD, US.
Daniel C GibbonsGSK, London, UK.
David WebbGSK, London, UK.
Xiaocong L MarstonOPEN Health, Bethesda, MD, US.
Myriam Na AlexanderOPEN Health, Marlow, UK.
Fanny S Mitrani-GoldGSK, Collegeville, PA, US fanny.s.mitrani-gold@gsk.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUncomplicated urinary tract infections (uUTIs) are common bacterial infections.

aimTo evaluate the burden of uUTI in England for 1) potential determinants of disease progression; 2) extent and impact of antimicrobial prescribing non-concordant with treatment guidelines; and 3) healthcare burden and economic costs. DESIGN &

settingRetrospective cohort study utilising patient data (January 2017-February 2020) from the Clinical Practice Research Datalink (CPRD) linked to English Hospital Episode Statistics.

methodFemale patients aged ≥12 years with a new uUTI between 2018 and 2019, ≥14 months' continuous CPRD enrolment (≥12 months baseline, ≥2 months follow-up), and ≥1 oral antibiotic prescription ±5 days of uUTI diagnosis were included. Baseline characteristics were described in patients with or without disease progression (hospitalisation for acute pyelonephritis, bacteraemia, or sepsis). Treatment non-concordance with current English guidelines was assessed. Burden (all-cause and urinary tract infection-related healthcare resource use [HCRU] and costs) was evaluated in a 1:1 age and comorbidity-matched uUTI-free cohort.

resultsOf 120 519 patients, 207 (0.2%) had disease progression requiring hospitalisation (during index uUTI episode); determinants included older age, index uUTI home consultation, prior hospitalisation, and medications prescribed for comorbid conditions in the prior 12 months (

conclusionAll-cause HCRU burden and costs were significantly higher in patients with uUTI versus matched controls (

Indexed as

community-acquired infectionscystitisgeneral practicelower urinary tract symptomsurinary tract infections

Identifiers

PMID39667795
PMCPMC12421281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.